128 related articles for article (PubMed ID: 2787853)
21. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
22. Histogenesis of Reed-Sternberg and dendritic interdigitating cells in nodular sclerosing Hodgkin's disease. Immunohistochemical evidence for monocytoid precursors.
Brown RE
Ann Clin Lab Sci; 1997; 27(5):329-37. PubMed ID: 9303171
[TBL] [Abstract][Full Text] [Related]
23. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants.
Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I
J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498
[TBL] [Abstract][Full Text] [Related]
24. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.
Kadin ME; Muramoto L; Said J
Am J Pathol; 1988 Feb; 130(2):345-53. PubMed ID: 2963547
[TBL] [Abstract][Full Text] [Related]
25. An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel.
Abdulaziz Z; Mason DY; Stein H; Gatter KC; Nash JR
Histopathology; 1984 Jan; 8(1):1-25. PubMed ID: 6368356
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
Frierson HF; Innes DJ
Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
[TBL] [Abstract][Full Text] [Related]
27. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.
Siebert JD; McClure SP; Banks PM; Gulley ML
Arch Pathol Lab Med; 1995 May; 119(5):474-9. PubMed ID: 7538289
[TBL] [Abstract][Full Text] [Related]
28. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
Coles FB; Cartun RW; Pastuszak WT
Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
[TBL] [Abstract][Full Text] [Related]
29. Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases.
Zarate-Osorno A; Medeiros LJ; Danon AD; Neiman RS
Arch Pathol Lab Med; 1994 Mar; 118(3):270-4. PubMed ID: 8135630
[TBL] [Abstract][Full Text] [Related]
30. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
Schmidt U; Herbst J; Metz KA; Leder LD
J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
[TBL] [Abstract][Full Text] [Related]
31. Expression of heat shock protein 70 (HSP70) and EBV latent membrane protein 1 (LMP1) in Reed-Sternberg cells of Hodgkin's disease.
Takahashi H; Fujita S; Shibata Y; Tsuda N; Okabe H
Anal Cell Pathol; 1996 Nov; 12(2):71-83. PubMed ID: 8986292
[TBL] [Abstract][Full Text] [Related]
32. B- and T-lymphocytes in Hodgkin's disease. An immunohistochemical study utilizing heterologous and monoclonal antibodies.
Forni M; Hofman FM; Parker JW; Lukes RJ; Taylor CR
Cancer; 1985 Feb; 55(4):728-37. PubMed ID: 3155642
[TBL] [Abstract][Full Text] [Related]
33. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
Oka K; Mori N; Kojima M
Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
[TBL] [Abstract][Full Text] [Related]
34. L-428 Reed-Sternberg cells and mononuclear Hodgkin's cells arise from a single cloned mononuclear cell.
Newcom SR; Kadin ME; Phillips C
Int J Cell Cloning; 1988 Nov; 6(6):417-31. PubMed ID: 3230329
[TBL] [Abstract][Full Text] [Related]
35. [Hodgkin's disease--immunological aspects].
Plat M; Frank KH; Fleischer J; Plat U; Koslowski R
Allerg Immunol (Leipz); 1988; 34(3):139-58. PubMed ID: 3057835
[TBL] [Abstract][Full Text] [Related]
36. The reaction of xenogeneic and monoclonal antisera with Reed-Sternberg cells.
Stuart AE; Jackson E; Morris CS
J Pathol; 1982 Jun; 137(2):129-38. PubMed ID: 6979620
[TBL] [Abstract][Full Text] [Related]
37. Ultrastructural study of Reed-Sternberg cells. Comparison with transformed lymphocytes and histiocytes.
Glick AD; Leech JH; Flexner JM; Collins RD
Am J Pathol; 1976 Oct; 85(1):195-208. PubMed ID: 1086064
[TBL] [Abstract][Full Text] [Related]
38. Lymph node architecture in Hodgkin's disease: evidence for the role of the composite nodule in nodular sclerosing Hodgkin's disease.
Van Parys G; De Wolf-Peeters C; van den Oord JJ; Desmet VJ
Hematol Oncol; 1987; 5(2):147-54. PubMed ID: 3596471
[TBL] [Abstract][Full Text] [Related]
39. Hodgkin's disease - a 'B' neoplasm?
Staples WG; Visser AE
S Afr Med J; 1978 Jul; 54(5):186-8. PubMed ID: 309183
[TBL] [Abstract][Full Text] [Related]
40. On the natural biology of the malignant cells in Hodgkin's disease.
Olsson L
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):37-48. PubMed ID: 3871433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
